CSL is interested in respiratory therapeutics in the areas of Interstitial Lung Diseases (ILD) and Acute Respiratory Distress Syndrome (ARDS).
For ILD‐related research, halting and reversing fibrosis is a key element of interest. For ARDS‐related research, a focus on Community Acquired Pneumonia (CAP) is of key importance.
In order to submit your available opportunities to these campaigns, please register to access your own dashboard from the links above. Once registered you will be able to submit opportunities to this campaign and stay updated about new campaigns from companies wishing to partner. For this campaign CSL have requested you provide a one-page summary of your opportunity, as well as any publicly available information on additional documents.